Afya (AFYA) Projected to Post Earnings on Thursday

Key Points

• Afya is slated to report Q1 2026 results after the market closes on May 14, with analysts forecasting $0.54 EPS and $192.95 million in revenue.
• In its last quarter Afya posted $0.41 EPS (beating estimates) but missed on revenue, and analysts expect about $2 EPS for the current and next fiscal year; the stock trades at a market cap of roughly $1.33 billion with a P/E of 9.74.
• Insiders have been net sellers (including the CFO's sale of 10,000 shares), with 123,547 shares sold last quarter (~$1.85M), while analysts hold a consensus "Hold" rating and a $17.20 price target.

Afya (NASDAQ:AFYA - Get Free Report) is projected to release its Q1 2026 results after the market closes on Thursday, May 14th. Analysts expect Afya to post earnings of $0.54 per share and revenue of $192.9470 million for the quarter. Interested persons can check the company's upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, May 7, 2026 at 5:00 PM ET.

Afya (NASDAQ:AFYA - Get Free Report) last announced its quarterly earnings data on Wednesday, March 11th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.05. The business had revenue of $147.08 million during the quarter, compared to the consensus estimate of $174.74 million. Afya had a net margin of 20.31% and a return on equity of 18.77%. On average, analysts expect Afya to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Afya Stock Up 2.1%

Shares of NASDAQ AFYA opened at $14.22 on Thursday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.20 and a quick ratio of 2.20. The company has a market cap of $1.33 billion, a P/E ratio of 9.74, a PEG ratio of 0.94 and a beta of 0.36. Afya has a 1 year low of $13.00 and a 1 year high of $19.90. The firm has a 50-day simple moving average of $14.56 and a two-hundred day simple moving average of $14.64.

Afya Announces Dividend

The company also recently disclosed an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were paid a $0.656 dividend. The ex-dividend date of this dividend was Wednesday, March 25th. This represents a yield of 433.0%. Afya's dividend payout ratio (DPR) is presently 45.21%.

Analysts Set New Price Targets

Several brokerages have issued reports on AFYA. UBS Group reissued a "neutral" rating and issued a $16.00 price objective (down from $18.00) on shares of Afya in a research note on Friday, January 16th. JPMorgan Chase & Co. decreased their price objective on shares of Afya from $22.00 to $21.50 and set a "neutral" rating for the company in a research note on Thursday, April 30th. Zacks Research raised shares of Afya from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, April 7th. Weiss Ratings reissued a "hold (c)" rating on shares of Afya in a research note on Monday, April 20th. Finally, Bank of America downgraded shares of Afya from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $22.00 to $17.00 in a research note on Tuesday, February 24th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $17.20.

Insider Buying and Selling at Afya

In other news, CFO Luis Andre Carpintero Blanco sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, April 8th. The shares were sold at an average price of $15.20, for a total transaction of $152,000.00. Following the transaction, the chief financial officer directly owned 51,103 shares of the company's stock, valued at approximately $776,765.60. This trade represents a 16.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Santos Welder Ferreira sold 3,325 shares of the firm's stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $15.90, for a total transaction of $52,867.50. Following the transaction, the insider directly owned 35,000 shares in the company, valued at approximately $556,500. This trade represents a 8.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 123,547 shares of company stock valued at $1,854,920. 0.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Afya

A number of institutional investors have recently modified their holdings of the stock. XTX Topco Ltd purchased a new position in shares of Afya during the fourth quarter worth approximately $215,000. Mangrove Partners IM LLC purchased a new position in shares of Afya during the fourth quarter worth approximately $197,000. State Street Corp increased its holdings in Afya by 25.8% during the fourth quarter. State Street Corp now owns 126,914 shares of the company's stock valued at $1,955,000 after buying an additional 26,005 shares during the period. Campbell & CO Investment Adviser LLC increased its holdings in Afya by 45.3% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company's stock valued at $612,000 after buying an additional 12,365 shares during the period. Finally, Daiwa Securities Group Inc. purchased a new position in Afya during the fourth quarter valued at approximately $43,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.